Biotech Company Leads Potential 'GLP-1 Moment for Hair Loss,' Says BTIG

BTIG initiated research coverage on a biotech company with a buy rating, suggesting its experimental hair loss treatment could be a 'GLP-1 moment' for the condition, akin to the impact of GLP-1 drugs on weight loss.